|
|
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2693-2699.
Prepublished online as a Blood First Edition Paper on June 23, 2005; DOI 10.1182/blood-2005-03-1131.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells
Colleen Delaney,
Barbara Varnum-Finney,
Keisuke Aoyama,
Carolyn Brashem-Stein, and
Irwin D. Bernstein
From the Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and Department of Pediatrics, University of Washington, Seattle, WA.
Although significant advances have been made over the last decade with respect to our understanding of stem cell biology, progress has been limited in the development of successful techniques for clinically significant ex vivo expansion of hematopoietic stem and progenitor cells. We here describe the effect of Notch ligand density on induction of Notch signaling and subsequent cell fate of human CD34+CD38– cord blood progenitors. Lower densities of Delta1ext-IgG enhanced the generation of CD34+ cells as well as CD14+ and CD7+ cells, consistent with early myeloid and lymphoid differentiation, respectively. However, culture with increased amounts of Delta1ext-IgG induced apoptosis of CD34+ precursors resulting in decreased cell numbers, without affecting generation of CD7+ cells. RNA interference studies revealed that the promotion of lymphoid differentiation was primarily mediated by Delta1 activation of Notch1. Furthermore, enhanced generation of NOD/SCID repopulating cells was seen following culture with lower but not higher densities of ligand. These studies indicate critical, quantitative aspects of Notch signaling in affecting hematopoietic precursor cell-fate outcomes and suggest that density of Notch ligands in different organ systems may be an important determinant in regulating cell-fate outcomes. Moreover, these findings contribute to the development of methodology for manipulation of hematopoietic precursors for therapeutic purposes.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Lahmar, C. Catelain, S. Poirault, M. Dorsch, J.-L. Villeval, W. Vainchenker, O. Albagli, and E. Lauret
Distinct Effects of the Soluble Versus Membrane-Bound Forms of the Notch Ligand Delta-4 on Human CD34+CD38low Cell Expansion and Differentiation
Stem Cells,
March 1, 2008;
26(3):
621 - 629.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Blank, G. Karlsson, and S. Karlsson
Signaling pathways governing stem-cell fate
Blood,
January 15, 2008;
111(2):
492 - 503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. V. Komanduri, L. S. St. John, M. de Lima, J. McMannis, S. Rosinski, I. McNiece, S. G. Bryan, I. Kaur, S. Martin, E. D. Wieder, et al.
Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing
Blood,
December 15, 2007;
110(13):
4543 - 4551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Mansour, V. Duke, L. Foroni, B. Patel, C. G. Allen, P. J. Ancliff, R. E. Gale, and D. C. Linch
Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
December 1, 2007;
13(23):
6964 - 6969.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Schiedlmeier, A. C. Santos, A. Ribeiro, N. Moncaut, D. Lesinski, H. Auer, K. Kornacker, W. Ostertag, C. Baum, M. Mallo, et al.
HOXB4's road map to stem cell expansion
PNAS,
October 23, 2007;
104(43):
16952 - 16957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Aoyama, C. Delaney, B. Varnum-Finney, A. D. Kohn, R. T. Moon, and I. D. Bernstein
The Interaction of the Wnt and Notch Pathways Modulates Natural Killer Versus T Cell Differentiation
Stem Cells,
October 1, 2007;
25(10):
2488 - 2497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Fung, S.-M. T. Tang, J. P. Canner, K. Morishige, J. F. Arboleda-Velasquez, A. A. Cardoso, N. Carlesso, J. C. Aster, and M. Aikawa
Delta-Like 4 Induces Notch Signaling in Macrophages: Implications for Inflammation
Circulation,
June 12, 2007;
115(23):
2948 - 2956.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Koga, N. Yamaguchi, T. Abe, M. Minegishi, S. Tsuchiya, M. Yamamoto, and N. Minegishi
Cell-cycle-dependent oscillation of GATA2 expression in hematopoietic cells
Blood,
May 15, 2007;
109(10):
4200 - 4208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. N. Barker
Umbilical Cord Blood (UCB) Transplantation: An Alternative to the Use of Unrelated Volunteer Donors?
Hematology,
January 1, 2007;
2007(1):
55 - 61.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Palomero, W. K. Lim, D. T. Odom, M. L. Sulis, P. J. Real, A. Margolin, K. C. Barnes, J. O'Neil, D. Neuberg, A. P. Weng, et al.
NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth
PNAS,
November 28, 2006;
103(48):
18261 - 18266.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Neves, F. Weerkamp, A. C. Gomes, B. A. E. Naber, P. Gameiro, J. D. Becker, P. Lucio, N. Clode, J. J. M. Van Dongen, F. J. T. Staal, et al.
Effects of Delta1 and Jagged1 on Early Human Hematopoiesis: Correlation with Expression of Notch Signaling-Related Genes in CD34+ Cells
Stem Cells,
May 1, 2006;
24(5):
1328 - 1337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Yu, J. K. Alder, J. H. Chun, A. D. Friedman, S. Heimfeld, L. Cheng, and C. I. Civin
HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding
Stem Cells,
April 1, 2006;
24(4):
876 - 888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. G. Leong and A. Karsan
Recent insights into the role of Notch signaling in tumorigenesis
Blood,
March 15, 2006;
107(6):
2223 - 2233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
